Boston Scientific engineers are working with Mayo Clinic physicians to develop new medical technologies in areas that comprise of interventional cardiology, heart rhythm management, endoscopy, neuromodulation, urology and pelvic health.

The collaboration allows both parties to lend ideas and intellectual property in resolving medical problems.

Boston Scientific president and CEO Michael Mahoney said: "Open approaches to innovation, such as our collaboration with Mayo Clinic, can more quickly put better tools and devices in the hands of physicians to improve the health and well-being of patients."

Both will work on several programs, including two Mayo Clinic studies that assessing a guide catheter designed to allow a physician to pass a guidewire across a narrowed aortic valve as part of the procedure for catheter-based aortic valve replacement.

The programs also involve the study, which will evaluate the use of Boston Scientific Precision Spectra spinal cord stimulator system to block the neural signals that activate shortness of breath and muscle fatigue during exercise among patients with heart failure.

Mayo Clinic president and CEO Dr John Noseworthy said: "Working together can allow us to swiftly bring our discovery and innovation to the direct benefit of patients."

The partnership is being managed through Mayo Clinic Ventures.